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Background: Isodon rugosus is used in folk Pakistan traditional practices to cure ailments related to gastrointestinal,
respiratory and cardiovascular problems. Present study was undertaken to validate these folkloric uses.
Methods: A crude methanol extract of the aerial parts of Isodon rugosus (Ir.Cr.) was used for both in vitro and
in vivo experiments. The plant extract was tested on isolated rabbit jejunum preparations for possible presence of
spasmolytic activity. Moreover, isolated rabbit tracheal and aorta preparations were used to ascertain the relaxant
effects of the extract. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of Ir.Cr were also
determined as well as its antioxidant activity. The in vivo antiemetic activity of the extract was evaluated by using
the chick emesis model, while the analgesic and antipyretic activities were conducted on albino mice.
Results: The application of the crude extract of I. rugosus to isolated rabbit jejunum preparations exhibited relaxant
effect (0.01-0.3 mg/ml). The Ir.Cr also relaxed K+(80 m M)-induced spastic contractions in isolated rabbit jejunum
preparations and shifted the Ca+2 concentration response curves towards right (0.01-0.3 mg/ml). Similarly, the
extract, when applied to the isolated rabbit tracheal preparations relaxed the carbachol (1 μM)- as well as K+
(80 mM)-induced contractions in a concentration range of 0.01-1.0 mg/ml. Moreover, it also relaxed (0.01-3.0 mg/ml) the
phenylephrine (1 μM)- and K+ (80 mM)-induced contractions in isolated rabbit aorta preparations. The Ir.Cr (80 mg/kg)
demonstrated antipyretic activity on pyrogen-induced pyrexia in rabbits as compared to aspirin as standard drug. The Ir.Cr
also exhibited anti-oxidant as well as inhibitory effect on acetyl- and butyryl- cholinesterase and lipoxygenase (0.5 mg/ml).
Conclusions: The observed relaxant effect on isolated rabbit jejunum, trachea and aorta preparations caused by Ir.Cr is
possibly to be mediated through Ca+2 channel blockade and therefore may provided scientific basis to validate the folkloric
uses of the plant in the management of gastrointestinal, respiratory and cardiovascular ailments. The observed antioxidant
activity as well as the lipoxygenase inhibitory activity may validate its traditional use in pain and inflammations.
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Isodon rugosus Wall. ex Benth. (Lamiaceae), locally known
as boi, sperkai and phaypush, is found in Northern areas
of Pakistan [1-4]. The plant is an aromatic, branched
shrub, 1-5 ft in height, with erect stem, ovate leaves of
notched margin and covered with dense small hairs on* Correspondence: hawazej@gmail.com; defeo@unisa.it
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unless otherwise stated.ventral side. It flowers from July to September and the
seeds ripen from August to October [5].
The plant is used in traditional medical practices in
tooth ache and is claimed to be effective as an antiseptic,
a hypoglycaemic, an anti-diarrheal and a bronchodilator
[2,3]. A topical administration of fresh leaf extract is
used to treat scabies for its immediate effect, while 1-2
drops of this extract are used to treat earache [6]. An ex-
tract of leaves is also used to treat hypertension, fevers,
rheumatism and toothache. Branches are used for mak-
ing dusters [1,7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vealed the presence of steroids, flavonoids, terpenoids,
saponin, tannins, cardiac glycosides, coumarins, redu-
cing sugars and β-cyanin among the methanol soluble
extractable constituents. From the plant, some diterpe-
noids, i.e. rugosinin, effusanin-A, effusanin-B, effusanin-E,
lasiokaurin and oridonin, have been isolated. The com-
pounds exhibited DNA protective activity in yeast strains
[8,9]. Moreover, the analysis of volatile oil fractions
from leaves and inflorescence indicated presence of
sesquiterpene hydrocarbons, including β-caryophyllene,
germacrene-D and α-humulene as the major constituents
[10]. Furthermore, plant extracts and fractions by different
solvents exhibited antifungal [5], antibacterial, phytotoxic
[11] and antioxidant activities [12].
Smooth muscle contractile activity plays a vital role in
regulating functions of gastrointestinal (GIT), respiratory
and cardiovascular systems in human body. Malfunction
of smooth muscle contractility in any of these systems
leads to many GIT disorders like intestinal spasms and
cramps; cardiovascular disorders like hypertension and
hypotension and airway disorders like asthma. Smooth
muscle activity is regulated by the cytosolic Ca2+ level,
and the sensitivity to Ca2+ of the contractile elements in
response to changes in the environment surrounding the
cell [13]. Plant extracts can stimulate, coordinate, and re-
store smooth muscle activity of gastrointestinal (GIT), re-
spiratory and cardiovascular systems. Since rabbit GIT,
aorta as well as trachea shares many physiological, ana-
tomical and pharmacological similarities of similar human
organs and are therefore used to study effect plant on
smooth muscle. There are many studies describing effect
of plant extracts on isolated smooth muscle tissue of vari-
ous animal models including rabbit [14-29]. Natural anal-
gesics are used to control pain. Analgesic activity of plant
extracts is evaluated using various animal models, the
most common being tail flick model due to its reliability
and minimal interanimal variation. Many studies have
been carried out by using this model [30-34]. Similarly
chick emesis model is mostly used in Pakistan [35-39].
Despite the tagged multiple therapeutic benefits of I.
Rugosus in asthma, GIT, cardiovascular problems as well
as its use as anti-emetic and analgesic remedy, no data is
available with respect to its effectiveness in ailments of
any of these vital organs of human body. The present
study on the crude extract of I. rugosus and its fractions
was undertaken using various pharmacological models
to rationalize these traditional uses and to explore mech-
anistic basis for these medicinal uses.
Methods
Collection of Plant and preparation of extract
The aerial parts of Isodon rugosus were collected from
the rural areas of Swat, Pakistan in September, 2011.The plant was identified by the taxonomist, Ms Saima
Shehzadi from the Institute of Pure and Applied Biology,
Bahauddin Zakariya University, Multan and a voucher
specimen of the plant was deposited in the herbarium of
this Institute (voucher # F.P.241-5). The plant material
was shade dried, rendered free of adulterants and
grinded into coarse powder. Approximately 500 g pow-
dered plant material was soaked in 80% aqueous-
methanol by cold maceration at room temperature for
7 days with occasional shaking. The filtration through
Whatman-1 filter paper was preceded by passage through
a muslin cloth to avoid choking by vegetative debris. The
filtrate was evaporated to a brownish green extract
under reduced pressure on a rotary evaporator at room
temperature, with a yield of 12%. The stock solutions
of Isodon rugosus were prepared in distilled water and
the dilutions were made fresh in normal saline on the
day of experiment.Chemicals
Acetylcholine chloride, atropine sulfate, carbachol, hista-
mine, isoprenaline, pyrillamine, potassium chloride, ver-
apamil hydrochloride and phenylephrine, magnesium
chloride, ethylene tetra-acetic acid (EDTA) were pur-
chased from Sigma Chemicals Co. St. Louis, MO, USA.
Calcium chloride, glucose, magnesium sulphate, potas-
sium dihydrogen phosphate, sodium bicarbonate, sodium
dihydrogen phosphate, and methanol were obtained from
Merck, Darmstadt, Germany. Ammonium hydroxide,
sodium chloride, and sodium hydroxide were purchased
from BDH Laboratory supplies, Poole, England. The
above-mentioned chemicals were of highest purity and
reagent analytical research grade.Animals and housing conditions
Animals (♂/♀) used in this study were local strain rabbits
(1.0-1.8 kg), mice (Swiss albino 28-30 g) and chicks (white
leghorn meant for laying eggs). Animals were housed
under controlled environmental condition (23-25°C) at
the animal house of Faculty of Pharmacy, Bahauddin
Zakariya University, Multan. The animals were provided
with standard food and tap water ad libitum. The animals
were deprived of food 24 hr prior to the experiments but
were given free access to water. Rabbits were sacrificed
following a blow on back of head to be used for in vitro
studies. All the experiments performed complied with the
rulings of Institute of Laboratory Animal Resources, Com-
mission on Life Sciences [40]. The experimental protocols
regarding current study were submitted to and approved
by the ethical committee meeting held on 14-02-2011
via Notification Number EC/02/2011 dated of the De-
partment of Pharmacy, Bahauddin Zakariya University,
Multan.
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The experiments on isolated tissues were performed by
adoption of procedures as described previously [24-27].
Briefly, we used freshly prepared jejunum, tracheal and
aortic tissue segments from the rabbit and maintained
adequately in the respective buffer solutions. The de-
tailed elaboration of each tissue extraction procedure is
described below under the respective heading (a-c).
Isolated rabbit jejunum preparations
The plant extract was tested on isolated rabbit jejunum
preparations for detecting a possible presence of spas-
molytic activity. Rabbit was dissected to remove jejunum
and this was placed in a Tyrode physiological salt solu-
tion maintained at 37°C and aerated with carbogen (95%
O2 and 5% CO2). The tissue were cut into segments of
about 2 cm in length, rendered free of adhering mesen-
teries and were subsequently suspended in isolated tis-
sue baths containing Tyrode’s solution, at 37°C and
aerated with carbogen. The composition of the Tyrode’s
solution (mM) was: KCl (2.68), NaCl (136.9), MgCl2
(1.05), NaHCO3 (11.90), NaH2PO4 (0.42), CaCl2 (1.8)
and glucose (5.55). A preload tension of 1 g was applied
and intestinal contractions were recorded isotonically
through a Powerlab Data Acquisition System (AD In-
struments, Sydney, Australia). The tissues were allowed
to equilibrate for about 30 min prior to exposure to any
test material. The isolated rabbit jejunum preparations
exhibit spontaneous rhythmic contractions and allow
testing of the relaxant (spasmolytic) effect without appli-
cation of an agonist [25]. The response observed on
addition of test material to isolated tissue bath was
quantified by dose addition in cumulative manner. The
observed relaxant effects of test substance were quanti-
fied as the percent decrease in spontaneous contractions
of the preparation recorded immediately prior to the
addition of test substances. The possible mechanism of
the relaxant activity of the test material was investigated
through the relaxation of K+ (80 mM)-induced sustained
spasmodic contractions [25,27]. The test material was
added to isolated tissue bath in a cumulative manner to
relax sustained contractions in concentration-dependent
manner. The observed relaxant effect of the test material
on K+ (80 mM)- induced contraction was expressed as
percent of the control contractile response.
Calcium channel blocking effect of the test substance
was confirmed by the method described previously [24,26].
The isolated rabbit jejunum preparation was allowed to
stabilize in normal Tyrode’s solution, which was subse-
quently replaced for 30 min with Ca2+-free Tyrode’s solu-
tion to which EDTA (0.1 mM) was added in order to
remove calcium from the tissue. The isolated tissue bath
solution was further replaced with K+-rich and Ca2+- free
Tyrode’ssolution, having the following composition (mM):KCl (50), NaCl (91.04), MgCl2 (1.05), NaHCO3 (11.90),
NaH2PO4 (0.42), glucose (5.55) and EDTA (0.1). Subse-
quent to an incubation period of 30 min, Ca2+ was added
to the tissue bath in cumulative manner to obtain control
calcium concentration response curves (CRCs). The CRCs
were prepared in duplicate and tissue was then washed
and allowed to be equilibrated in the presence of plant ex-
tract for 1 hour prior to recording of the concentration re-
sponse curves of Ca2+ for comparison to the control
concentration response curves. The CRCs of Ca2+ were re-
corded in the presence of different concentrations of the
plant extract in tissue bath.
Isolated rabbit tracheal preparations
Rabbit trachea was dissected out as described previously
[27,41] and kept in a Krebs solution having the following
composition (mM): NaCl (118.2), NaHCO3 (25.0), CaCl2
(2.5), KCl (4.7), KH2PO4 (1.3), MgSO4 (1.2) and glucose
(11.7). The trachea was cleaned free from the surround-
ing fatty tissues and rings of 2–3 mm width containing
2–3 cartilages were prepared. Each ring was opened by a
longitudinal incision on the ventral side opposite to the
smooth muscles layer to form a strip with smooth mus-
cles layer in middle and cartilages on both sides. These
tracheal tissues were mounted in 20 ml organ bath con-
taining the Krebs solution being maintained at 37°C and
aerated with carbogen. A preload tension of 1 g was ap-
plied and tissue preparations were allowed to be equili-
brated for 1 hour prior to any challenge by the drug.
The Ir.Cr was added to the isolated tissue bath in differ-
ent concentrations in cumulative manner to assess the
possible relaxant effect on carbachol (1 μM)- and high
K + (80 mM)-induced sustained contractions. The iso-
metric contractile responses were recorded through a
Powerlab Data Acquisition System (AD Instruments,
Sydney, Australia) linked to a computer installed with a
Lab Chart software (Version 7). The standard drug, Ver-
apamil, with Ca2+ channel blocking effect, was tested on
carbachol (1 μM)- and K+ (80 mM)- induced spastic
contractions to evaluate the possible mode of action.
Isolated rabbit aorta preparation
The descending thoracic aorta was dissected out and
kept in Krebs solution at 37°C and aerated with carbo-
gen. It was cut into rings of about 2–3 mm in width and
each ring and was mounted in a tissue bath containing
the Krebs solution at 37°C and aerated with carbogen. A
preload tension of 2 g was applied to each preparation
and allowed to equilibrate for a period of 1 hour. Vasor-
elaxant effects of Ir.Cr were assessed on phenylephrine
(1 μM)- and K+ (80 mM)-induced spastic contractions
in isolated tissue preparations. Changes in isometric
tension of aortic rings were recorded via a force-
displacement transducer coupled to a Powerlab Data
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linked to a computer installed with Lab Chart software
(version 7).
Cholinesterases and lipoxygenase activity
The acetylcholinesterase (AChE electrical eel, Type VI-S,
EC 3.1.1.7; Sigma) and butyrylcholinesterase (BuChE
equine serum EC 3.1.1.8; Sigma) inhibitory activities of
Ir.Cr were determined subsequent to minor modifica-
tion of previously reported spectrophotometric method
[42] by using 96-well plate reader Synergy HT, Biotek,
USA, taking eserine (0.25 mM per well) as standard in-
hibitor. The acetylcholinesterase/butyrylcholinesterase
activity was estimated following hydrolysis of substrate
like acetylthiocholine/butyrylthiocholine (Sigma) by re-
spective cholinesterases into thiocholine, which on reaction
with 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) produced
a yellow product (5-thio-2-nitrobenzoic acid) at PH 8 and
maximum absorbance was measured at 405 nm after
15 min incubation at 37°C. The inhibitory influence of Ir.
Cr (0.5 mg/ml) and eserine (0.25 mM) on AChE and
BuChE activity was assessed by repeating the above-
mentioned procedure in the presence of test compounds
in the reaction mixture. Ethanol was taken as negative con-
trol. The IC50 values were determined on addition of mul-
tiple dilution of Ir.Cr (i.e. 0.5, 0.25, 0.125, 0.0625, 0.0313,
0.015 mg/ml) and eserine (i.e. 0.5, 0.25, 0.125, 0.0625,
0.0313, 0.015 mM) to the reaction mixtures and data ob-
tained was analyzed on EZ–Fit Enzyme kinetics software
(Perrella Scientific Inc. Amherst, USA) decrease in absorb-
ance indicated increase in enzyme inhibitory activity.
Moreover, the lipoxygenase (LOX) inhibitory activity was
assayed following the method proposed by Tappel [43].
The decrease in absorbance indicates increased en-
zyme inhibition activity which was determined by the
following formula.
Inhibition %ð Þ ¼ Abs:of control–Abs:of test solutionð Þ
 100 Abs:of control
Where
Absorbance of Control ¼ Total enzyme activity
without inhibitor
Absorbance of Test ¼ Activity in the presence of
test compound
Determination of antioxidant activity
The antioxidant activity was determined by DPPH assay,
which was carried out following the protocol of previ-
ously reported method [44]. Ascorbic acid was used as a
standard antioxidant and all experiments were carried
out in triplicates. The reduction in the absorbance was
measured at 517 nm using a Synergy HT BioTek® USAmicroplate reader and data obtained was computed on
Ez-fit software.
Anti-emetic activity
The antiemetic activity of the Ir.Cr was evaluated by
using chick emesis model [45]. The chicks were placed
under large beakers and were acclimatized for 30 min.
The animals of group 1 (n = 5) were given an oral dose
of normal saline and copper sulphate was given orally
(50 mg/kg) about 10 min after the last treatment. The
group 2 animals (n = 5) were treated similar to group 1
except normal saline was replaced by Ir.Cr (150 mg/kg;
solubilised in normal saline). Whereas, the group 3 of
animals (n = 5) were treated similar to group 2 of ani-
mals except chlorpromazine (150 mg/kg) was substituted
for Ir.Cr. The numbers of retches were counted during
the next 10 minutes and the percent inhibition was eval-
uated by the formula as given below:
“Inhibition %ð Þ ¼ A−B=Að Þx100”
Where,
A ¼ Frequency of retching in control group
B ¼ Frequency of retching in test group
Analgesic activity
The screening for analgesic activity was conducted on
albino mice subsequent to minor modifications of the
previously reported technique [46]. The tails of mice
were dipped in water maintained at 55°C, while holding
animals in vertical position. The time taken by mice to
withdraw its tail out of water was the reaction time. The
reaction time was noted prior to treatment of a group of
mice (n = 5) and Ir.Cr (200 mg/kg; i.p., dissolved in nor-
mal saline) was injected after 10 min of noting reaction
time and reaction time was noted after 15 min of Ir.Cr
treatment. In a similar group of mice (n = 5), the
above-mentioned procedure was repeated except as-
pirin (75 mg/kg; I.P) was substituted for Ir.Cr.
Antipyretic activity
The Ir.Cr was subjected to screening for possible antipyr-
etic activity following minor modification of the previously
reported method [47]. The albino rabbits (1-1.5 kg) were
divided in to 3 groups each containing 5 animals. The
group 1 animals were regarded as control, and was given
an i.p. injection (0.5 ml/kg) of pyrogen (brewer yeast) and
an injection of normal saline (2 ml/kg) about 40 min of
after first treatment. The group 2 animals were designated
as experimental and were treated similar to group 1 ani-
mals except the Ir.Cr (80 mg/kg) dissolved in normal sa-
line (2 ml) was substituted for normal saline. The group 3
animals were considered as standard and received
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(10 mg/kg) dissolved in normal saline (2 ml) was
injected intraperitoneally. The rectal temperatures of
the rabbits were noted after every 5 min with clinical
thermometer by inserting to the rectum to the extent
of about 0.5 cm subsequent to lubrication of thermom-
eter bulb with glycerine till the temperature become
normal.
Statistical analysis
The values were expressed as mean ± standard error
(Mean ± SE). Student’s t-test was applied for assessment
of observations. P < 0.05 was believed to be statistically
significant.
Results
Effect of Ir.Cr on isolated rabbit jejunum preparations
The application of the methanol extract of Isodon rugo-
sus to the isolated rabbit jejunum preparations exerted
relaxant effect at a tissue bath concentration range of
0.1-0.3 mg/ml, with an EC50 value of 0.16 mg/ml (95%
CI:0.01-0.291; n = 5) (Figure 1). The Ir.Cr also caused re-
laxation of K+(80 mM)-induced spastic contractions at a
tissue bath concentration of 0.3 mg/ml and EC50 value
of 0.15 mg/ml (95% CI:0.01-0.29; n = 5) (Figure 2). The
Ir.Cr-induced relaxant effect was found to be compar-
able to the effect of the standard drug, verapamil, which
relaxed the spontaneous and K+(80 mM)-induced con-
tractions with respective EC50 value of 0.65 μM (95%
CI:0.5551-0.8601; n = 5) and 0.70 μM (95% CI:0.5777-
0.8881; n = 5) (Figure 2).
To assess the potential Ca2+ antagonistic effect, Ir.Cr
was also tested on the control concentration response
curve of calcium. The medium was Ca2+ free and the
spontaneous contractions of the isolated rabbit jejunum
preparations were eradicated completely but the cumu-
lative addition of Ca2+ (0.1–6.4 mM) caused a stepwise
restoration of the contractile activity in tissue and max-
imal contraction was attained at tissue bath concentra-
tion of 6.4 mM of Ca2+, which was assumed to be 100%.Figure 1 Tracings showing (a) spontaneous contraction of isolated ra
Isodon rugosus (Ir.Cr). Plant extract was added in cumulative manner and vSubsequently, the jejunum tissue incubated with Ir.Cr at
a concentration range of 0.1–0.3 mg/ml for 35 min
shifted the concentration response curve of Ca2+ to-
wards right. These effects were found to be similar to
those produced by verapamil (0.1–0.5 μM), (Figure 3,
n = 5).
Effect of Ir.Cr on isolated rabbit tracheal preparations
The Ir.Cr caused relaxation of the carbachol (CCh)
(1 μM)- and K+ (80 mM)–induced contractions in isolated
rabbit tracheal preparations at the tissue bath concentra-
tions ranging from 0.1 to 0.3 mg/ml, with respective EC50
value of 0.22 mg/ml (95% CI:0.01-0.74; n = 5) and
0.20 mg/ml (95% CI:0.01-0.57; n = 5) (Figure 4a,b,c). Simi-
larly, verapamil relaxed the CCh (1 μM)- induced contrac-
tions with EC50 of 0.6910 mg/ml (95% CI:0.5551-0.8601;
n = 5), as well as K+(80 mM)-induced contractions with
EC50 of 0.6910 mg/ml (95% CI:0.5551-0.8601; n = 5)
(Figure 4d).
Effect of Ir.Cr on isolated rabbit aorta preparations
The Ir.Cr exhibited relaxant effect on isolated rabbit
aorta preparations. It caused relaxation of K+ (80 mM)
and phenylephrine (1 μM)-induced contractions with
EC50 values of 0.21 mg/ml (95% CI:0.011-0.57; n = 5)
and 1.43 mg/ml (95% CI:0.01-2.74; n = 5), respectively
(Figure 5a,b,c). These effects were comparable to those
of verapamil, which relaxed the phenylephrine- and
K+(80 mM)- induced contractions with respective EC50 of
0.90 μM (95% CI:0.03-5.02; n = 5) and 0.43 μM (95%
CI: 0.03-1.98; n = 5) (Figure 5d).
Effect of Ir.Cr on cholinesaterases and lipoxygenase
enzymatic activity
The methanol extract of Isodon rugosus caused 41.66 ±
0.3% inhibition of AChE activity at a concentration of
0.5 mg/ml, while the standard drug, eserine, caused an
inhibition of 91.29 ± 1.17% of AChE activity at 0.25 mM
concentration. The IC50 value for AChE after Ir.Crbbit jejunum and (b) spasmolytic effect of the crude extract of

































Figure 2 Concentration dependent relaxant effect of (a and b) methanol extract of Isodon rugosus (Ir.Cr) and (c) verapamil on
spontaneous and high K + (80 mM)- induced contractions in isolated rabbit jejunum preparations. Values are the mean ± SEM, n = 5.
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it was estimated as 0.14 ± 0.001 mM (Table 1).
The Ir.Cr caused 33.78 ± 0.5% inhibition of butyrylcho-
linesterase (BchE) enzyme at a concentration of 0.5 mg/ml,
whereas eserine exhibited 82.82 ± 1.09 inhibition of BchE
at 0.25 mM concentration. The IC50 value of Ir.Cr for BchE
was found to be 0.74 ± 0.02 mg/ml, whereas it was calcu-
lated to be 0.15 ± 0.02 μM for serine (Table 1).
The extract (0.5 mg/ml) exerted 36.65 ± 2.8% inhib-
ition of lipoxygenase in comparison to the standard
durg, baicalin (0.25 mM/L), which exhibited 93.79 ±



















Figure 3 Effect of (a) methanol extract of Isodon rugosus (Ir.Cr) and (b
rabbit jejunum preparations. Values are the mean ± SEM, n = 5.0.68 ± 0.07 mg/ml and 0.13 ± 0.015 mM, respectively
(Table 1).
Anti-oxidant activity of Ir.Cr
The Ir.Cr exhibited 41.26 ± 0.2% scavenging activity
against DPPH at a concentration of 0.5 mg/ml as com-
pared to the standard ascorbic acid, which showed 92 ±
0.1% activity (Table 2).
Anti-emetic activity of Ir.Cr
In the control group of animals to whom normal saline



















































Figure 4 Concentration dependent inhibitory effect of (a, b and c) methanolic extract of Isodon rugosus (Ir.Cr) and (d) verapamil on































Figure 5 Concentration dependant inhibitory effect of (a, b and c) methanolic extract of Isodon rugosus (Ir.Cr) and (d) verapamil on
phenylephrine (1 μM)- and high K + (80 mM)- induced contractions in isolated rabbit aorta preparations. Values are the mean ± SEM, n = 5.
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Table 1 Inhibitory activity of Ir.Cr on cholinesterases and lipoxygenase enzymatic activities in comparison to
respective standards
Enzymatic activity Test material Conc./well % Inhibition IC50
Acetylcholinesterase Ir.Cr 0.5 mg/ml 41.66 ± 0.3 0.6 ± 0.04 mg/ml
Eserine* 0.25 mM 91.29 ± 1.17 0.14 ± 0.001 mM
Butyrylcholinesaterase Ir.Cr 0.5 mg/ml 33.78 ± 0.5 0.74 ± 0.02 mg/ml
Eserine 0.25 mM 82.82 ± 1.09 0.15 ± 0.02 mM
Lipoxygenase Ir.Cr 0.5 mg/ml 36.65 ± 2.8 0.68 ± 0.07 mg/ml
Baicalin** 0.25 mM 93.79 ± 1.38 0.13 ± 0.015 mM
*Standard for cholinesterases; **standard for lipoxygenase.
Table 3 Anti-emetic effect of Ir.Cr in comparison to
chlorpromazine
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retches were 58.8 ± 0.1. The group of animals was
treated similarly, but Ir.Cr (150 mg/kg) substituted the
normal saline, showed a significantly reduced number of
retches (46.2 ± 0.3) (p <0.01). This value was found to be
comparable to a group of animals treated with the stand-
ard anti-emetic, chlorpromazine (150 mg/kg), where
retches were significantly (p <0.01) decreased to 46.0 ±
0.2. Thus Ir.Cr (150 mg/kg) exhibited a significant anti-
emetic activity (21.42%; p < 0.01), in a manner compar-
able to chlorpromazine (150 mg/kg) as standard drug
(21.76%; p < 0.01) (Table 3).
Analgesic activity of Ir.Cr
The duration of tail deflection prior to drug administra-
tion was 2.73 ± 0.01 s, but Ir.Cr (200 mg/kg; i.p., diluted
in saline) treatment resulted in a significantly (p <0.01)
increased deflection time, i.e., 9.35 ± 0.08 s. Similarly, the
treatment with aspirin (75 mg/kg; i.p. diluted in saline)
also resulted in a significant (p <0.01) increase in tail de-
flection time in mice (9.62 ± 0.2 s). Thus, Ir.Cr treatment
exerted analgesic effect in mice in terms of increase in
tail deflection time in a manner similar to aspirin used
as a standard analgesic drug (Table 4).
Antipyretic effect of Ir.Cr
Animals of control group, to whom (0.5 ml/kg; i.p.) of
pyrogen (brewer yeast) was injected at 0 time, presented
a rectal temperature of 38.44 ± 0.1°C. Two hrs after nor-
mal saline was injected subsequent and rectal temperature
was 40.16 ± 0.2°C. The values of rectal temperature at 3, 4
and 5 hrs were 40.12 ± 0.1, 40.10 ± 0.01 and 40.10 ± 0.1°C,
respectively. The animals of treated group received a simi-
lar treatment except for administration of Ir.Cr (80 mg/kg;
i.p., diluted in saline) in substitution of saline; the rectal
temperatures at 0, 2, 3, 4 and 5 hrs 37.9 ± 0.2, 39.05 ± 0.05,Table 2 Anti-oxidant activity of Ir.Cr
Sample Concentration % Inhibition
Ir.Cr 0.5 mg/ml 41.26 ± 0.02
Ascorbic acid 0.3 mM/L 92 ± 0.138.85 ± 0.07, 38.38 ± 0.2, and 38.38 ± 0.1°C, respectively.
The animals of aspirin group received a similar treatment
except for administration of aspirin (10 mg/kg; i.p., diluted
in saline) and temperatures noted at 0, 2, 3, 4 and 5 hrs
were 38.93 ± 0.1, 38.71 ± 0.2, 38.06 ± 0.1, 38.32 ± 0.2, and
39.20 ± 0.1°C, respectively. There was a significant (P <
0.05) rise in temperature subsequent to pyrogen injection
in all the control group of animals but only Ir.Cr and as-
pirin treatments resulted in significant decrease in body
temperature, thus indicating a potential antipyretic effect
of Ir.Cr (Table 5).
Discussion
Isodon rugosus has folkloric repute to be beneficial in
the management of multiple ailments pertaining to
gastrointestinal, respiratory and cardiovascular systems.
GIT disorders such as, indigestion and constipation are
believed as root cause of many diseases and indigenous
communities in Pakistan use plant parts to cure them as
herbal therapy. The present study was undertaken for
the scientific validation of these folkloric claims through
an exploration of the possible mechanism(s) of action.
The application of the methanol extract of Isodon
rugosus to the spontaneously contracting isolated rabbit
jejunum preparations showed a relaxant effect, as reflected
by decrease in both amplitude and frequency of the spon-
taneous contractions. The spontaneous movements of in-
testine is a phenomenon of alternative depolarization and
repolarization and the maximal depolarization is mediated
through action potential produced via rapid influx of Ca2+
by means of voltage dependant L-type Ca2+ channels
(VDLCs) [48]. The increased availability of Ca2+ in cyto-
plasm results in enhanced contraction of smooth muscleGroups No. of retches ± S.E.M % Inhibition
of emesis
Control (10 ml/kg) 58.8 ± 0.1 Nil
Chlorpromazine (150 mg/kg) 46.0 ± 0.2 21.76
Ir.Cr (150/mg/kg) 46.2 ± 0.3 21.42
Table 4 Effect of Ir.Cr and aspirin on tail deflection
time (s) in mice
Groups Control Treated Standard
Dosage Saline
10 ml/kg




2.73 ± 0.1 9.35 ± 0.8 9.62 ± 0.2
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agonists, i.e., acetylcholine, histamine and serotonin [49].
The possible mechanism of observed relaxant effect by
the extract was tested against the K+(80 mM)-induced
contractions in isolated rabbit jejunum. The exposure to
K+(>30 mM) can induce contraction of smooth muscles
through opening of voltage dependent calcium channels,
increased influx of extracellular Ca+2 leading to contract-
ile effect [50]. The substances capable to relax K+
(80 mM)-induced contractions are speculated to act
through blockade of Ca+2 channels [51]. The Ca+2 chan-
nel blocking activity of Ir.Cr was further confirmed by
the rightward shift of calcium concentration response
curves in isolated rabbit jejunum preparation in a man-
ner similar to verapamil. Calcium channel blockers are an
essential class of drugs demonstrating dose-dependent in-
hibition of Ca+2 influxes [52].
The Ir.Cr was found to cause relaxation of both carba-
chol (1 μM)- and K+(80 mM)- induced contractions in
isolated rabbit tracheal preparations and such non-
specific relaxant effect is likely to be mediated through
Ca+2 channel blockade [53] .
Moreover, Ir.Cr exerted relaxant effect on application
to isolated rabbit aortic preparations and also relaxed
phenylephrine- and K+ (80 mM)-induced contractions.
The isolated rabbit aortic preparation has been used to
elaborate mechanism of calcium channel blocking activ-
ity [25,26] as K+ (80 mM)-induced contractions are me-
diated through activation of Ca+2 channels as well as
release of Ca+2 from endoplasmic reticulum, whereas
mechanism underlying the phenylephrine-induced con-
tractions is through the activation of α-adrenergic recep-
tors and subsequent Ca+2 influx through the receptor
mediated Ca+2 channels. The Ir.Cr was able to relax
both phenylephrine- and K+ (80 mM)-induced contrac-
tions likely to mediate through Ca+2 channel blockade.
The presence of alkaloids and saponins as the plant con-
stituents, may explain the gut stimulant actions of theTable 5 Effect of Ir.Cr on pyrogen-induced pyrexia in rabbit
Groups Treatment
0 hr
Control Pyrogen + Saline 38.44 ± 0.1 4
Ir.Cr Pyrogen + Ir.Cr 80 mg/kg 37.9 ± 0.2 39
Aspirin Pyrogen + Aspirin 10 mg/kg 38.93 ± 0.1 3plant extract as these are believed to possess gut stimu-
latory properties.
Antiemetic activity was performed at doses (50 mg/kg,
100 mg/kg, 150 mg/kg, 200 mg/kg). 150 mg/kg was ob-
served to be more potent antiemetic dose. Analgesic ac-
tivity was performed at doses (100 mg/kg, 200 mg/kg,
300 mg/kg). 200 mg/kg showed effective analgesia. Anti-
pyretic activity was performed at doses (50 mg/kg,
80 mg/kg, 10 mg/kg). 80 mg/kg of the crude extract was
potent antipyretic. In these activities dose higher than
the potent dose was found to be toxic. Antioxidant ac-
tivity was performed in vitro. It was not tested in vivo.
The antioxidant potential of Ir.Cr was explored
through in vitro studies. The free radical formation and
reactive oxygen and nitrogen species are involved in
various ailments including cancer, arthritis, heart dis-
eases, immune defects and neurodegenerative disorders
including aging process. Hence, use of Ir.Cr may play a
role in amelioration of disease process of above men-
tioned diseases due to itsantioxidant activity.
Moreover, Ir.Cr was found to be a good inhibitor of
acetylcholinestrase and butyrylcholinesterase and both
enzymes play a significant role in modulation of activity
level through increase in acetylcholine levels at synaptic
clefts. Several agents capable to inhibit acetycholinester-
ase are valuable for the management of disease condi-
tions like myasthenia gravis, characterized by increased
muscle weakness and intense fatigue [54-56]. Similarly,
acetycholinesterase inhibitors have also been used in
Alzheimer’s disease, in which the cholinergic impairment
caused dementia and other nervous problems [57]. Few
other plants have been reported to share this capability
to inhibit acetylcholinesterase and have shown thera-
peutic potential against the Myasthenia gravis and Alz-
heimer’s disease, e.g., Salvia lavandulaefolia [58,59] and
Salvia chionthana [60].
Furthermore, Ir.Cr caused significant inhibition of
lipoxygenase enzyme, which is known to cause conver-
sion of arachidonic acid into leukotrienes (LTs) [61],
whereas LTs C4, D4, and E4, collectively known as
cysteinyl LTs, are products of 5-lipoxygenase [62]. Ini-
tially, these were reputed as potent constrictors of re-
spiratory tract but it has been subsequently realized to
cause inflammation, increase in capillary permeability
and increase in mucus secretion, which may exacerbate
asthma and allergic rhinitis. These are known to beRectal temperatures
2 hs 3 hs 4 hs 5 hs
0.16 ± 0.2 40.12 ± 0.1 40.10 ± 0.1 40.10 ± 0.1
.05 ± 0.05 38.85 ± 0.07 38.37 ± 0.02 38.37 ± 0.03
8.71 ± 0.2 38.06 ± 0.1 38.32 ± 0.2 39.20 ± 0.1
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receptor 1 (CysLT1), hence, antagonism of CysLT1 and
inhibition of 5-LO are reported to have therapeutic po-
tential to manage asthmatic condition [63]. We can
hypothesize that the inhibition of lipoxygenase by Ir.Cr
may be useful in management of asthma and allergic
rhinitis.
The Ir.Cr was found to exhibit antipyretic activity as it
caused inhibition of pyrogen-induced pyrexia. The pyr-
exia is caused by the access of pro-inflammatory media-
tors (prostaglandins and other metabolites of arachidonic
acid) to thermostat in hypothalamus; hence pyrexia is an
outcome of disturbed thermostat in hypothalamus [64]. It
is possible that the observed antipyretic effect is mediated
by a limited availability of prostaglandins through inhib-
ition of cyclooxygenase, as it has already been found to in-
hibit lipoxygenase.
The pain sensation is generated by interaction of pros-
taglandins with pain receptors [65,66]. The prostaglan-
dins are produced by action of cyclooxygenase 1 and
cyclooxygenase 2 on ω-3 and ω-6 C20 fatty acids [67].
The methanol extract of Isodon rugosus demonstrated a
significant analgesic effect in tail flick experiments per-
formed on mice, and this is likely mediated through
theinhibition of cyclooxygenase, resulting in a limited
availability of prostaglandin for action on nociceptors. It
also indicates central mediated nociception through opi-
oid receptors.
The Ir.Cr demonstrated antiemetic properties in-vivo in
chicks after administration of copper sulphate. The vomit-
ing centre lies in the medulla oblongata, by activation of
motor pathways descending from this centre. The vomiting
centre can be activated directly by irritants or indirectly
following input from 4 principal areas, i.e., gastrointestinal
tract, cerebral cortex and thalamus, vestibular region, and
chemoreceptor trigger zone (CTZ). The CTZ is in vicinity
to medulla and contrary to other brain centres it is not
protected by the blood-brain barrier [68]. The observed
anti-emetic effect of Ir.Cr can be likely mediated through
inhibition of CRTZ.
Conclusions
The observed relaxant effect on isolated rabbit jejunum,
trachea and aorta preparations showed by the methanol
extract of Isodon rugosus can be likely mediated through
Ca+2 channel blockade and may provided scientific basis
to validate the folkloric uses of the plant in the manage-
ment of gastrointestinal, respiratory and cardiovascular
ailments. The observed antioxidant activity as well as
the lipoxygenase inhibitory activity of Ir.Cr may validate
its folkloric use in pain and inflammations. We used
crude extract of plant which is a combination of mul-
tiple constituents. So exact constituent responsible for
these activities should be pinpointed by conductingfurther research and exploring the individual constitu-
ent. The bioactive constituent responsible should be iso-
lated, quantified and its structure should be elaborated
by analytical techniques.
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